NASDAQ Companies

First quarter record revenues of $8.4 Million, up 47% year over year; IFRS gross margin climbed to 78% compared to […]

EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) — NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive […]

REHOVOT, Israel, May 21, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage […]

PURCHASE, N.Y., May 21, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage […]

Hosted Event with Local Government Officials, Taxation Bureau, and Customs Officials to Educate and Promote the Center SHENZHEN, China, May […]

MIAMI, May 21, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), today announced that the U.S. Food […]

LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject […]

MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and […]

LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 […]

Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue […]